Game-changing Strategies of European Pharma Companies

Strong Focus on Digital Footprint and Beyond-the-pill Services Propel Companies to Innovate and Stay on the Growth Trajectory

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing European pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights on the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalisation of key processes across drug development and manufacturing. It analyzes the dynamics catalyzing growth, profiles organizations presenting significant growth opportunities, and outlines innovative industry trends of key participants who play a vital role in the pharmaceutical landscape.

The research covers the top 5 European pharmaceutical companies, based on their industry position. The companies included in the study are Bayer, AstraZeneca, Roche, Novartis, and Sanofi. These companies are benchmarked across 5 key growth levers, namely core areas of focus, digital footprint, value chain excellence, strategic collaborations and partnerships, and beyond-the-pill services and solutions.

Highlights of the company profiles include:
•     Company snapshot
•     Performance analysis (market revenue forecast)
•     Portfolio analysis
•     Key marketed products and patent expiry
•     SWOT analysis
•     Strategic analysis of growth levers

Table of Contents

Game-changing Strategies of European Pharma CompaniesExecutive SummaryExecutive SummaryKey Questions this Study will AnswerEuropean Pharma EcosystemEuropean Pharma Ecosystem5 Big Themes for Innovation in European Pharma Companies5 Big Themes for Innovation in European Pharma CompaniesTop 10 European Pharma CompaniesT10 European Pharma CompaniesStrategic Growth Lever 1—Focus on Core AreasFocus on Core AreasStrategic Growth Lever 2—Digital FootprintDigital FootprintStrategic Growth Lever 3—Value Chain ExcellenceValue Chain ExcellenceStrategic Growth Lever 4—Strategic Collaborations/Alliances or PartnershipsStrategic Collaborations/Alliances or Partnerships Strategic Growth Lever 5—Beyond-the-pill Services and SolutionsBeyond the Pill Services and Solutions Company Profile—Bayer Bayer Company SnapshotCompany Performance AnalysisCompany Portfolio AnalysisTop 10 Marketed Products and Patent ExpiriesCompany SWOT AnalysisStrategic Analysis of Growth Levers Company Profile—AstraZenecaAstraZeneca Company SnapshotCompany Performance AnalysisCompany Portfolio AnalysisTop 10 Marketed Products and Patent ExpiriesCompany SWOT AnalysisStrategic Analysis of Growth Levers Company Profile—Novartis Novartis Company SnapshotCompany Performance AnalysisCompany Portfolio AnalysisTop 10 Marketed Products and Patent ExpiriesCompany SWOT AnalysisStrategic Analysis of Growth Levers Company Profile—Roche Roche Company SnapshotCompany Performance AnalysisCompany Portfolio AnalysisTop 10 Marketed Products and Patent ExpiriesCompany SWOT AnalysisStrategic Analysis of Growth Levers Company Profile—SanofiSanofi Company SnapshotCompany Performance AnalysisCompany Portfolio AnalysisTop 10 Marketed Products and Patent ExpiriesCompany SWOT AnalysisStrategic Analysis of Growth LeversThe Last WordThe Last WordLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Related Research

Release Date : 29-Mar-17

Region : Europe

Release Date : 4-May-2016

Region : Europe

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.